Episurf Medical to present at Stockholm Corporate Finance 13th Life Science Seminar on March 24, 2021

Episurf Medical (Nasdaq: EPIS B) will attend Stockholm Corporate Finance 13th Life Science Seminar, which are capital market days held on 23 – 24 of March, 2021. The event is arranged by Stockholm Corporate Finance and the company will be represented by the CEO Pål Ryfors.

The presentation will be available live at 10:00 CET on Wednesday March 24. Register as a participant at https://www.lyyti.fi/reg/scf-life-science-seminarium-2021  

For more information, please contact:

Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com

About Episurf Medical

Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.